Eiger BioPharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eiger BioPharmaceuticals, Inc. has filed 694 SEC EDGAR filings since 05 Oct 2004

SEC filing history

Showing 101-125 of 687 matching filings.

Per page
25
Current page
5
SC 13G/A File 005-87931

SC 13G/A

Filing date
10 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jan 2023
Reporting date
29 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Dec 2022
Reporting date
22 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Dec 2022
Reporting date
22 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Aug 2022
Reporting date
16 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2022
Reporting date
18 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
19 Jul 2022
Reporting date
18 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SC 13G/A

Filing date
11 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

EIGER BIOPHARMACEUTICALS, INC.

Filing date
02 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36183

DEFA14A

Filing date
28 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36183

DEF 14A

Filing date
28 Apr 2022
Reporting date
16 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-251497

424B5

Filing date
25 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .